Pear Therapeutics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Pear Therapeutics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10495
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive designed for schizophrenia; reCALL using virtual reality exposure therapy to treat combat posttraumatic stress disorder (PTSD); reVIVE against general anxiety disorder; and PEAR-005 to PEAR-011 for treating pain, major depressive disorder, insomnia, Parkinson’s disease and inflammatory conditions. Pear Therapeutics reSET, is an FDA-authorized prescription therapeutic for substance use disorder (SUD) used as an outpatient treatment. The company works in partnership with Center for Technology and Behavioral Health, Dartmouth College, Ehave, Inc., Intellectual Ventures Management LLC, Novartis AG, and others. Pear Therapeutics is headquartered in Boston, Massachusetts, the US.

Pear Therapeutics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pear Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pear Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Pear Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pear Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Pear Therapeutics Raises USD50 Million in Series B Financing 10
Pear Therapeutics Raises USD20 Million in Equity Financing Round 12
Pear Therapeutics Raises Additional Funds through Venture Financing 13
Pear Therapeutic Raises Funds Through Crowdfunding 14
Partnerships 15
Pear Therapeutics Enters into Agreement with Sandoz 15
Pear Therapeutics Enters into Agreement with Novartis 16
Pear Therapeutics Inc – Key Competitors 17
Pear Therapeutics Inc – Key Employees 18
Pear Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Pear Therapeutics Inc, Medical Equipment, Key Facts 2
Pear Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pear Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pear Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Pear Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pear Therapeutics Raises USD50 Million in Series B Financing 10
Pear Therapeutics Raises USD20 Million in Equity Financing Round 12
Pear Therapeutics Raises Additional Funds through Venture Financing 13
Pear Therapeutic Raises Funds Through Crowdfunding 14
Pear Therapeutics Enters into Agreement with Sandoz 15
Pear Therapeutics Enters into Agreement with Novartis 16
Pear Therapeutics Inc, Key Competitors 17
Pear Therapeutics Inc, Key Employees 18
Pear Therapeutics Inc, Other Locations 19

List of Figures
Pear Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pear Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pear Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Pear Therapeutics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hydrodec Group Plc (HYR):石油・ガス:M&Aディール及び事業提携情報
    Summary Hydrodec Group Plc (Hydrodec) is an oil and gas company that offers oil refining services. The company produces, markets and distributes transformer oil and naphthenic base oil. It undertakes collection, transportation and processing of used non-PCB and PCB-contaminated naphthenic-based tran …
  • Litgrid AB (LGD1L):企業の財務・戦略的SWOT分析
    Litgrid AB (LGD1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pint Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a pharmaceutical company which develops, manufactures and markets originator drugs focused in rare disease, oncology and specialty pharma. The company offers wide range of products in the form of tablets, inject …
  • Career Education Corporation (CECO):企業の財務・戦略的SWOT分析
    Career Education Corporation (CECO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Svelte Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Svelte Medical Systems Inc (Svelte) is a medical device company that manufactures and designs balloon expandable stents. The company offers products such as balloon expandable stents, svelte acrobat, and drug eluting stents, among others. Its svelte acrobat is a stent-on-a-wire bare metal co …
  • Frontera Energy Corp (FEC):企業の財務・戦略的SWOT分析
    Frontera Energy Corp (FEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • British Broadcasting Corporation:戦略・SWOT・企業財務分析
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Kimball International, Inc.
    Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Skechers U.S.A., Inc. (SKX):企業の財務・戦略的SWOT分析
    Skechers U.S.A., Inc. (SKX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • ARUP Laboratories-医療機器分野:企業M&A・提携分析
    Summary ARUP Laboratories (ARUP) is a clinical and anatomical pathology reference laboratory. It is a nonprofit enterprise of the University of Utah and its Department of Pathology. The company provides several tests and test combinations in the fields of anatomic pathology, genetics, pain managemen …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Federal Signal Corp (FSS):企業の財務・戦略的SWOT分析
    Federal Signal Corp (FSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rosenergoatom Concern:電力:M&Aディール及び事業提携情報
    Summary Rosenergoatom Concern (Rosenergoatom) is a subsidiary of Atomenergoprom, which is electric power generation company, mainly supplying electrical and thermal energy in Russia. The company’s major activities include design, construction, operation and decommissioning of nuclear power plants. T …
  • Berry Global Group Inc:戦略・SWOT・企業財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Key Energy Services, Inc. (KEG)-石油・ガス分野:企業M&A・提携分析
    Summary Key Energy Services, Inc. (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, …
  • Broadridge Financial Solutions, Inc.:企業の戦略・SWOT・財務分析
    Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Lantheus Medical Imaging Inc:企業の製品パイプライン分析2018
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Sanochemia Pharmazeutika AG (SAC):企業の財務・戦略的SWOT分析
    Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆